The epidemiology of acute respiratory distress syndrome in pediatric intensive care units in China.
OBJECTIVE
To assess the incidence of, predisposing factors for, and the rates and relative risks of mortality from acute respiratory distress syndrome (ARDS) in pediatric patients.


METHODS
A prospective study in 12 consecutive months from 2004 to 2005 in 25 pediatric intensive care units (PICUs).


METHODS
ARDS was diagnosed according to the 1994 American-European Consensus Conference definitions, applied to all severely ill admissions between 1 month and 14 years of age. The PICUs were in major municipalities and provincial cities, and half were university affiliated.


RESULTS
From a total of 12,018 admissions, 7,269 were severely ill. One hundred and five (1.44%) patients developed ARDS and 64 (61.0%) died, which accounts for 13.2%, of the total ICU death (n = 485, 6.7%) or a nine times relative risk of dying. The median age at onset of ARDS was 24 months and 40% were less than 12 month old. Median time from PICU admission to the onset of ARDS was 16 h, and in 63% <24 h. Pneumonia (55.2%) and sepsis (22.9%) were the major predisposing factors for ARDS. These were respectively 14 and 5 times as high a death rate as those of the severely ill patients without ARDS.


CONCLUSIONS
ARDS has a high mortality in these Chinese PICUs, especially in those with pneumonia and sepsis, and adequate management including lung protective ventilation strategy is required.
Yu
Wen-Liang
WL
Children's Hospital of Fudan University, 183 Feng Lin Road, 200032, Shanghai, People's Republic of China.
Lu
Zhu-Jin
ZJ
Wang
Ying
Y
Shi
Li-Ping
LP
Kuang
Feng-Wu
FW
Qian
Su-Yun
SY
Zeng
Qi-Yi
QY
Xie
Min-Hui
MH
Zhang
Guo-Ying
GY
Zhuang
De-Yi
DY
Fan
Xun-Mei
XM
Sun
Bo
B
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D015278:Intensive Care Units, Pediatric / Q000706:statistics & numerical data*; D008171:Lung Diseases / Q000401:mortality* / Q000628:therapy; D008297:Male; D011014:Pneumonia / Q000150:complications / Q000453:epidemiology; D012121:Respiration, Artificial / Q000706:statistics & numerical data; D018805:Sepsis / Q000150:complications / Q000453:epidemiology; D013577:Syndrome